Abstract
In this study, we investigated whether the anti-inflammatory drug PP56 (alpha-trinositol) may improve cancer-induced metabolic disorders. We implanted human MiaPaCa2 pancreatic cancer cells in the pancreas of 14 athymic mice for 12 weeks, using six intact littermates as normal controls. During the 12 weeks, seven tumor-cell recipients were treated with PP56 by daily injection (PPT mice). The tumor-cell recipients that were otherwise untreated were used as tumor controls (TC mice). Impaired glucose tolerance and decreased body weight gain were seen in TC but not PPT mice. When an enzyme for fatty acid β-oxidation namely medium-chain acyl-CoA dehydrogenase (MCAD) was determined in tumor grafts; tumors from PPT mice showed more MCAD than those from TC mice. This suggests that PP56 stimulated fatty acid β-oxidation in MiaPaCa2 cells in vivo. In keeping with this notion, PPT mice had decreased plasma free fatty acids. In vitro, we demonstrated that MiaPaCa2 cells consumed more fatty acids in the presence of PP56. In another experiment, we infused PP56 or vehicle in normal mice and found that PP56 decreased circulating glucose in the animals. We also showed that PP56 increased glucose transport in L6 skeletal muscle cells in vitro. In conclusion, PP56 increases the turnover of circulating nutrients such as glucose and helps maintain energy homeostasis in mice with pancreatic cancer.
Similar content being viewed by others
References
Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg. 1993;159:101–7.
Bell D, McDermott BJ. D-myo inositol 1, 2, 6, triphosphate (alpha-trinositol, pp 56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling? Gen Pharmacol. 1998;31:689–96.
Nedrebo T, Reed RK, Berg A. Effect of alpha-trinositol on interstitial fluid pressure, edema generation, and albumin extravasation after ischemia-reperfusion injury in rat hind limb. Shock. 2003;20:149–53.
Tarnow P, Cassuto J, Jönsson A, Rimbäck G, Hedman C. Postoperative analgesia by D-myo-inositol-1, 2, 6-trisphosphate in patients undergoing cholecystectomy. Anesth Analg. 1998;86:107–10.
Ahrén B. Inhibitory effect of D-myo-inositol-1, 2, 6-trisphosphate on glucose-stimulated insulin secretion in the mouse. Neuropeptides. 1992;21:163–6.
Ruf JC, Ciavatti M, Gustafsson T, Renaud S. Effects of PP-56 and vitamin E on platelet hyperaggregability, fatty acid abnormalities, and clinical manifestations in streptozocin-induced diabetic rats. Diabetes. 1991;40:233–9.
Carrington AL, Calcutt NA, Ettlinger CB, Gustafsson T, Tomlinson DR. Effects of treatment with myo-inositol or its 1, 2, 6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol. 1993;237:257–63.
Wang F, Li SS, Segersvärd R, Strömmer L, Sundqvist KG, Holgersson J, et al. Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis. Am J Pathol. 2007;170:469–77.
Alpert E, Gruzman A, Lardi-Studler B, Cohen G, Reich R, Sasson S. Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin- and AMPKalpha-independent manner. Diabetologia. 2006;49:562–70.
Wyne KL. Free fatty acids and type 2 diabetes mellitus. Am J Med. 2003;115:29S–36.
Walsh DA, Mapp PI, Polak JM, Blake DR. Autoradiographic localization and characterization of [3H]alpha-trinositol (1D-myo-inositol 1, 2, 6-trisphosphate) binding sites in human and mammalian tissues. J Pharmacol Exp Ther. 1995;273:461–9.
Russell ST, Siren PM, Siren MJ, Tisdale MJ. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1, 2, 6-triphosphate. Cancer Chemother Pharmacol. 2009;64:517–27.
Acknowledgements
We thank B. Hagman, A. Wagman, and I. Engström for technical assistance. This study was financed by a grant from the Swedish Cancer Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, F., Larsson, J., Herrington, M.K. et al. PP56 improves energy homeostasis in a mouse model of pancreatic cancer. Tumor Biol. 31, 309–313 (2010). https://doi.org/10.1007/s13277-010-0038-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-010-0038-4